Search Results for: FCER1G

Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel COX8A cytochrome c oxidase subunit 8A
  • TP53 Regulates Metabolic Genes
  • Respiratory electron transport
  • Cytoprotection by HMOX1
  • Complex IV assembly
  • Cholic Acid
  • N-Formylmethionine
Novel F5 coagulation factor V
  • Platelet degranulation
  • Common Pathway of Fibrin Clot Formation
  • COPII-mediated vesicle transport
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Cargo concentration in the ER
  • Post-translational protein phosphorylation
  • Drotrecogin alfa
  • Thrombomodulin Alfa
  • Thrombin
  • Protein C
  • Human thrombin
  • Thrombin alfa
  • Protein S human
  • Anti-inhibitor coagulant complex
  • Factor V deficiency; Owren disease
  • Inherited thrombophilia
Novel FCGR2A Fc gamma receptor IIa
  • FCGR activation
  • FCGR activation
  • Regulation of actin dynamics for phagocytic cup formation
  • Role of phospholipids in phagocytosis
  • Neutrophil degranulation
  • FCGR3A-mediated IL10 synthesis
  • Cetuximab
  • Etanercept
  • Human immunoglobulin G
  • Abciximab
  • Alemtuzumab
  • Daclizumab
  • Bevacizumab
  • Catumaxomab
  • Sarilumab
  • Systemic lupus erythematosus
Novel FCGR2B Fc gamma receptor IIb
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Etanercept
  • Human immunoglobulin G
  • Abciximab
  • Tositumomab
  • Alemtuzumab
  • Antithymocyte immunoglobulin (rabbit)
  • Palivizumab
  • Daclizumab
  • Bevacizumab
  • Sarilumab
  • Systemic lupus erythematosus
Novel MIF macrophage migration inhibitory factor
  • Cell surface interactions at the vascular wall
  • Neutrophil degranulation
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • 3,4-Dihydroxycinnamic Acid
  • 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester
  • 4-Hydroxyphenylpyruvic acid
  • 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER
  • 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
  • 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
  • 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME
  • 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE
Novel NHERF4 NHERF family PDZ scaffold protein 4
  • Intestinal infectious diseases
Novel NIT1 nitrilase 1
Novel PTPN5 protein tyrosine phosphatase non-receptor type 5
  • Interleukin-37 signaling
Novel SELP selectin P
  • Platelet degranulation
  • Cell surface interactions at the vascular wall
  • Heparin
  • N-acetyl-alpha-neuraminic acid
  • Dalteparin
  • Nadroparin
  • Crizanlizumab
Novel SPRR1A small proline rich protein 1A
  • Formation of the cornified envelope
ADGRE2 adhesion G protein-coupled receptor E2
  • Class B/2 (Secretin family receptors)
C2CD2L C2CD2 like
CDIPT CDP-diacylglycerol--inositol 3-phosphatidyltransferase
  • Synthesis of PI
  • scyllo-inositol
CERS4 ceramide synthase 4
  • Sphingolipid de novo biosynthesis
CLCA4 chloride channel accessory 4
  • Stimuli-sensing channels
CLEC4E C-type lectin domain family 4 member E
  • Dectin-2 family
  • Dectin-2 family
  • Cholesterol
CNIH1 cornichon family member 1
  • COPII-mediated vesicle transport
  • Cargo concentration in the ER
COX20 cytochrome c oxidase assembly factor COX20
  • Complex IV assembly
CYP4F2 cytochrome P450 family 4 subfamily F member 2
  • Fatty acids
  • Miscellaneous substrates
  • Eicosanoids
  • Synthesis of Leukotrienes (LT) and Eoxins (EX)
  • Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
DEFB127 defensin beta 127
  • Beta defensins
  • Defensins

Page 1 out of 5 pages